drugset / Trial / NCT01532336
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the clinical and microbiological efficacy and safety of NVC-422 compared to vehicle for adenoviral conjunctivitis. Adults and children one year of age and older with diagnosis of adenoviral conjunctivitis in at least one eye based upon a positive adenovirus test result using the Aden-Detactor Plus kit (Rapid Pathogen Screening, Inc). Subjects will be randomly assigned to receive either NVC-422 or Vehicle.
Timeline
- Start
- 2012-05
- Primary completion
- 2014-05
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NVC-422 | Unknown | 0.3 % | Other |